ALS-Associated E478G Mutation in Human OPTN (Optineurin) Promotes Inflammation and Induces Neuronal Cell Death
Year: 2018
Type: article
Abstract: Amyotrophic Lateral Sclerosis (ALS) is a group of neurodegenerative disorders that featured with the death of motor neurons, which leads to loss of voluntary control on muscles. The etiologies vary among different subtypes of ALS, and no effective management or medication could be provided to the patients, with the underlying mechanisms incompletely understood yet. Mutations in human Optn (Optineurin), particularly E478G, have been found in many ALS patients. In this work, we report that NF-κB activity was increased in Optn knockout (Optn-/-) MEF (mouse embryonic fibroblast) cells expressing OPTN of different ALS-associated mutants especially E478G. Inflammation was significantly activated in mice infected with lenti-virus that allowed overexpression of OPTNE478G mutation in the motor cortex, with marked increase in the secretion of pro-inflammatory cytokines as well as neuronal cell death. Our work with both cell and animal models strongly suggested that anti-inflammation treatment could represent a powerful strategy to intervene into disease progression in ALS patients who possess the distinctive mutations in OPTN gene.
Source: Frontiers in Immunology
Authors: Zhengzhao Liu, Hongming Li, Chungu Hong, Menglu Chen, Tao Yue, Chunyuan Chen, Zhenxing Wang, Qing You, Chuanyin Li, Qinjie Weng, Hui Xie, Ronggui Hu
Institutions: Central South University, Shenzhen University, Xiangya Hospital Central South University, Shenzhen Second People's Hospital, ShanghaiTech University, Center for Excellence in Molecular Cell Science, University of Chinese Academy of Sciences, State Key Laboratory of Molecular Biology, Zhejiang University
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,801
Funders: National Natural Science Foundation of China, Chinese Academy of Sciences, Central South University, China Postdoctoral Science Foundation, Natural Science Foundation of Guangdong Province, National Science and Technology Major Project, Xiangya Hospital, Central South University, Fundamental Research Funds for the Central Universities, Innovation-Driven Project of Central South University
OpenAlex ID: W2901044417
